Duration of illness and intelligence in schizophrenia

被引:0
|
作者
Wolitzky, R [1 ]
机构
[1] NYSPI, New York, NY USA
关键词
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页码:106 / 106
页数:1
相关论文
共 50 条
  • [1] Illness duration and neuropsychological impairments in schizophrenia
    Cuesta, MJ
    Peralta, V
    Zarzuela, A
    SCHIZOPHRENIA RESEARCH, 1998, 33 (03) : 141 - 150
  • [2] Duration of illness and structure of symptoms in schizophrenia
    Mojtabai, R
    PSYCHOLOGICAL MEDICINE, 1999, 29 (04) : 915 - 924
  • [3] AMPHETAMINE RESPONSE AND DURATION OF ILLNESS IN SCHIZOPHRENIA
    ANGRIST, B
    SANFILIPO, M
    WOLKIN, A
    SCHIZOPHRENIA RESEARCH, 1991, 5 (03) : 200 - 201
  • [4] THE EFFECT OF ILLNESS DURATION ON PERCEPTUAL ASYMMETRY IN SCHIZOPHRENIA
    CARR, V
    WALE, J
    DEWIS, S
    STEPHAN, L
    SCHIZOPHRENIA RESEARCH, 1992, 7 (03) : 211 - 216
  • [5] The deficit syndrome symptoms and duration of illness in schizophrenia
    Stanford, AD
    Yale, S
    Goetz, RR
    Corcoran, C
    Malaspina, D
    SCHIZOPHRENIA RESEARCH, 2004, 70 (01) : 120 - 121
  • [6] Neurological signs, age, and illness duration in schizophrenia
    Chen, EYH
    Lam, LCW
    Chen, RYL
    Nguyen, DGH
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 1996, 184 (06) : 339 - 345
  • [7] Symptom classification of schizophrenia changes with the duration of illness
    Hori, A
    Tsunashima, K
    Watanabe, K
    Takekawa, Y
    Ishihara, I
    Terada, T
    Uno, M
    ACTA PSYCHIATRICA SCANDINAVICA, 1999, 99 (06) : 447 - 452
  • [8] CSF ACE correlates with duration of illness in schizophrenia
    Wahlbeck, K
    Rimon, R
    SCHIZOPHRENIA RESEARCH, 1998, 29 (1-2) : 103 - 103
  • [9] Deficit syndrome symptoms and duration of illness in schizophrenia
    Stanford, AD
    Yale, S
    Goetz, RR
    Corcoran, C
    Malaspina, D
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S227 - S228
  • [10] Telomere Length in Schizophrenia as a Function of Age and Illness Duration
    Wolkowitz, Owen M.
    Palmer, Barton W.
    Glorioso, Danielle
    Thompson, Wesley
    Epel, Elissa S.
    Lin, Jue
    Blackburn, Elizabeth
    Jeste, Dilip V.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S347 - S348